| 1 Brummelkamp T R, Bernards R, et al. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002,296(5567): 550~553.2 Elbashir S M, Harborth J, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature,2001,411(6836): 494~498.3 Glaser K B, Li J, et al. Role of class Ⅰ and class Ⅱ histone deacetylases in carcinoma cells using siRNA. Biochem Biophys Res Commun,2003,310(2): 529~536.4 Glaser K B, Staver M J, et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. Mol Cancer Ther,2003,2(2): 151~163.5 Glozak M A,Seto E. Histone deacetylases and cancer. Oncogene,2007,26(37): 5420~5432.6 Gondi C S,Rao J S. Concepts in in vivo siRNA delivery for cancer therapy. J Cell Physiol,2009,220(2): 285~291.7 Halkidou K, Gaughan L, et al. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer. Prostate,2004,59(2): 177~189. 8 Ikura T, Ogryzko V V, et al. Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell,2000,102(4): 463~473.9 Johnstone R W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov,2002,1(4): 287~299.10Mahlknecht U,Hoelzer D. Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med,2000,6(8): 623~644.11Marks P, Rifkind R A, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer,2001,1(3): 194~202.12Nan X, Ng H H, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature,1998,393(6683): 386~389.13Patra S K, Patra A, et al. Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun,2001,287(3): 705~713.14Senese S, Zaragoza K, et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol,2007,27(13): 4784~4795.15Weber M, Moller K, et al. Short technical reports. Effects of lipopolysaccharide on transfection efficiency in eukaryotic cells. Biotechniques,1995,19(6): 930~940.16Whetstine J R, Ceron J, et al. Regulation of tissue-specific and extracellular matrix-related genes by a class Ⅰ histone deacetylase. Mol Cell,2005,18(4): 483~490.17Wilson A J, Byun D S, et al. Histone deacetylase 3 (HDAC3) and other class Ⅰ HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem,2006,281(19): 13548~13558.18Yoshida M, Horinouchi S, et al. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays,1995,17(5): 423~430.19Yoshikawa M, Hishikawa K, et al. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. Eur J Pharmacol,2010,642(1~3): 28~36.20Yu J Y, DeRuiter S L, et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA,2002,99(9): 6047~6052. |
